PD-L1 (121), as an immunosuppressive checkpoint, can promote immune escape, while WTAP can enhance its expression, strengthen the immune escape mechanism, prevent the anti-tumor effect caused by T cell proliferation (122), and promote the progression of CRC (123) (Figure 2). Here, WTAP is linked to neoplasm.